A comprehensive discussion on leveraging reverse engineering in the pursuit of cancer cures, alongside an exploration of technology's pivotal role in driving advancements in healthcare and society.
Nicolas Wolikow is a French entrepreneur and co-founder and CEO of Cure51. Since March 2022, Nicolas has been fully dedicated to Cure51 that has just raised a €15 million seed round to harness the natural power of cancer survivors and contribute to cure this life threatening disease. After graduating from Sciences Po and HEC, he pursued roles in marketing and international development within major French groups, like L'Oréal and Sodexo, before transitioning to technology, co-founding Talkway and later Dailymotion. He then ventured into the healthcare sector, serving in leadership positions at International SOS Group and co-founding Qare, eventually joining Ipsen as Chief Digital Officer after the sale of Qare in 2020.
NOTE: This calendar event does not update if there are any changes in the online program. You will not get a notification about any changes, but you can always check the TOA online community app for the most recent schedule.
